🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Anticoagulation

Preventing Stroke, Premature Death and Cognitive Decline in a Broader Community of Patients With Atrial Fibrillation NCT04700826Phase 41 site📍 Birmingham University of Birmingham · Tests: Direct Oral Anticoagulants SENIOR: Stroke Prevention in the Elderly by Patent Foramen Ovale closuRe vs Anticoagulation NCT07479147n/a3 sites📍 Taichung📍 Taipei📍 Taipei Taichung Veterans General Hospital · Tests: PFO closure, Medication Low-dose NOAC Versus GDMT After LAAO NCT05960721NA1 site📍 Xi'an Xijing Hospital · Tests: Rivaroxaban 15mg, Aspirin 100mg, Clopidogrel 75mg, Rivaroxaban 10mg, Rivaroxaban 2.5mg Long-term Anticoagulation With Oral Factor Xa Inhibitor Versus Vitamin K Antagonist After Mechanical Aortic Valve Replacement NCT04258488Phase 416 sites📍 Bucheon-si📍 Busan📍 Daegu Joon Bum Kim · Tests: Rivaroxaban Oral Tablet, Vitamin K antagonist(warfarin) The Direct Oral Anticoagulation Versus Vitamin K Antagonist After Cardiac Surgery Trial NCT04284839Phase 319 sites📍 Fitzroy📍 Parkville📍 Edmonton Population Health Research Institute · Tests: DOAC, VKA START-Register: Survey on Anticoagulated Patients Register NCT02219984n/a1 site📍 Bologna GUALTIERO PALARETI · Tests: Anticoagulants Catheter Ablation Plus LAAO Versus Anticoagulation in Frail Elderly Patients With Atrial Fibrillation NCT07441382NA1 site📍 Guangzhou Guangdong Provincial People's Hospital · Tests: catheter ablation combined with LAAO (Left Atrial Appendage Occlusion), Atrial Fibrillation Radiofrequency Ablation Only Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76) NCT05712200Phase 3789 sites📍 Birmingham📍 Birmingham📍 Birmingham Anthos Therapeutics, Inc. · Tests: Abelacimab, Placebo LAmbre Versus AMPLATZER Amulet Left AtrIal Appendage Occluder for StRoke ProphylaxIs NCT06060912NA1 site📍 Munich Deutsches Herzzentrum Muenchen · Tests: Left Atrial Appendage Occlusion Comparison of LAA-Closure vs Oral Anticoagulation in Patients With NVAF and Status Post Intracranial Bleeding. NCT04298723NA39 sites📍 Mannheim📍 Bad Neustadt an der Saale📍 Burgau Jena University Hospital · Tests: Percutaneous closure of the LAA (Watchman / Watchman FLX) Anticoagulation in ICH Survivors for Stroke Prevention and Recovery NCT03907046Phase 3187 sites📍 Birmingham📍 Mobile📍 Chandler Yale University · Tests: Apixaban, Aspirin The Southern-Norway Post-Stroke Atrial Fibrillation Study NCT07407790NA1 site📍 Kristiansand Sorlandet Hospital HF · Tests: Patch ECG, Standard Care (in control arm) Monitoring Bleeding of Patients Using NOAC Anticoagulation Therapy in Proximal Femoral Fracture Internal Fixation Surgery Without Waiting. We Measure Bleeding in Surgery and the Levels of Noac Drug in Blood. We Will Try to Compare to Regular Pateints Later NCT06644976n/a1 site📍 Kfar Saba Meir Hospital, Kfar Saba, Israel · Tests: femoral neck CRIF Efficacy of Prolonged Anticoagulation for Primary Prevention of Venous Thromboembolic Disease in Autoimmune Hemolytic Anemia: a Prospective, Phase II, Randomized, Multicenter Study NCT05089227Phase 21 site📍 Dijon Centre Hospitalier Universitaire Dijon · Tests: treatment "intervention", treatment "standard", biological assessment Safety Evaluation of Prismocitrate 18 in Patients Receiving CRRT NCT05399537Phase 314 sites📍 Birmingham📍 Los Angeles📍 Los Angeles Vantive Health LLC · Tests: Prismocitrate 18, PrisMax System Version 3.x with calcium line accessory Adverse Drug Events in Patients on Oral Anticoagulation in the Emergency Department NCT06692504n/a1 site📍 Besançon Centre Hospitalier Universitaire de Besancon Restarting Early Versus Later Anticoagulation for Chronic Subdural Hematoma With Atrial Fibrillation NCT06696079NA6 sites📍 Oulu📍 Kuopio📍 Tampere Rahul Raj · Tests: Early Resumption of Oral Anticoagulation Therapy, Late Resumption of Oral Anticoagulation Therapy Registry of Patients Prescribed Anticoagulation NCT03504007n/a1 site📍 Rochester Mayo Clinic Advancing Knowledge in Ischemic Stroke Patients on Oral Anticoagulants NCT06823466n/a47 sites📍 Zagreb📍 Copenhagen📍 Asyut University of L'Aquila Statins to Prevent Cancer Associated Blood Clots NCT07303816Phase 49 sites📍 Irvine📍 New Haven📍 Miami Brigham and Women's Hospital · Tests: Rosuvastatin, Placebo Drug Early Surgical Fixation of Low-Velocity Hip Fractures in Patients With Direct Oral Anticoagulation NCT05070169n/a1 site📍 Vienna Medical University of Vienna · Tests: Early Surgical Fixation vs. Delayed Surgical Fixation Timing of Venous Thromboembolism Prophylaxis in Patients With Hypertensive Intracerebral Hemorrhage NCT06753786NA1 site📍 Moscow Pirogov Russian National Research Medical University · Tests: Venous thromboembolism prophylaxis with unfractionated heparin or low molecular weight heparin starting within the firs… Comparative Efficacy of Rivaroxaban and Enoxaparin in Post-Laparotomy DVT Prevention NCT07243080Phase 41 site📍 Lahore Mayo Hospital Lahore · Tests: rivaroxaban (10mg), Enoxaparin 40 mg SC Stroke Prophylaxis With Apixaban in Chronic Kidney Disease Stage 5 Patients With Atrial Fibrillation NCT05679024Phase 334 sites📍 Helsinki📍 Tampere📍 Turku Region Stockholm · Tests: Apixaban 2.5 milligram Oral Tablet Anticoagulation in Post MI LV Thrombus Trial in Nepal NCT05794399Phase 41 site📍 Kathmandu Shahid Gangalal National Heart Centre · Tests: Rivaroxaban, Warfarin MENA Regional Endovascular Intervention for Venous Cerebral Venous Sinus Thrombosis NCT07548346NA14 sites📍 Alexandria📍 Cairo📍 Cairo Middle East North Africa Stroke and Interventional Neurothe… · Tests: Endovascular Thrombectomy, Anticoagulation Therapy Optimal Anti-Thrombotic Management Following Percutaneous Left Atrial Appendage Occlusion NCT07840365Phase 31 site📍 Austin Texas Cardiac Arrhythmia Research Foundation · Tests: Half-Dose of novel OAC, Low-dose ASA Intravenous Thrombolysis in Patients With Ischemic Stroke and Recent Ingestion of Direct Oral Anticoagulants NCT06556446n/a33 sites📍 Innsbruck📍 Brussels📍 Leuven Insel Gruppe AG, University Hospital Bern · Tests: Tenecteplase and Alteplase Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation for Whom Oral Anticoagulation is Unsuitable NCT07430956Phase 344 sites📍 Dothan📍 Glendale📍 Little Rock Regeneron Pharmaceuticals · Tests: REGN7508, REGN9933, Placebo Aspiration Thrombectomy Using the Symphony or Prodigy System NCT07350499n/a13 sites📍 Huntsville📍 Clearwater📍 Jacksonville Imperative Care, Inc. · Tests: Prodigy Thrombectomy System, Symphony Thrombectomy System, Symphony Thrombectomy System
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy